Analytical study of cytokines and chemokines in stored BALF in patients with acute exacerbation of fibrosing interstitial lung disease.

Analytical study of cytokines and chemokines in stored BALF associated with acute exacerbation of fibrosing interstitial lung disease. - Biomarker study in stored BALF in patients with acute exacerbation of fibrosing interstitial lung disease.

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000043034

Enrollment

Registered

2021-01-17

Start date

2020-12-07

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute exacerbation of fibrosing interstitial lung disease

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who enrolled in the "Acute exacerbation of fibrosing interstitial lung disease; multicenter retrospective cohort study" and who underwent BAL and had preserved specimens.

Exclusion criteria

Exclusion criteria: Cases in which the subject refuses to provide information Cases in which BAL specimens are not stored.

Design outcomes

Primary

Measure	Time frame
To evaluate the relationship between biomarkers in BALF and prognosis and treatment response.	—

Countries

Japan

Contacts

Public ContactKatsuyuki Furuta

Wakayama Medical University Department of Pulmonary Medicine and Medical Oncology

k-furuta@wakayama-med.ac.jp073-441-0619

Outcome results